NCT00203229View on ClinicalTrials.gov

Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

July 31, 2006

Conditions
Trigeminal Neuralgia
Interventions
DRUG

lamotrigine

The intervention type is 'drug' and this arm is a placebo pill created and supplied by the manufacturers of lamotrigine (Lamictal). This drug is an anti-seizure medication.

DRUG

Placebo

The intervention type is 'drug' and this arm is a placebo pill created and supplied by the manufacturers of lamotrigine (Lamictal) to be exact replicas of the actual drug being studied. The placebo arm is titrated in the exact same manor as the active drug arm.

Trial Locations (1)

19107

Jefferson Headache Center, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT00203229 - Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia | Biotech Hunter | Biotech Hunter